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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Diabetes is one of the leading causes of dialysis, blindness, and amputa-
tion worldwide. However, the prevalence of diabetes-related kidney, eye, and foot diseases
has not been investigated in national surveys.
Methods: In this study, we reviewed data sets of the National Health Insurance claims for the
years 2000e2009. In 2009, the total population of Taiwan was 23 million. We de-identified the
data and then analyzed them on inpatients and outpatients with diabetes mellitus, kidney
diseases, eye diseases, peripheral vascular diseases (PVDs), and diabetic foot according to
the International Classification of Diseases, 9th Revision with Clinical Modification diagnosis
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2.09.006
638 Y.-Y. Huang et al.Results: The prevalence of diabetic nephropathy increased from 13.32% in 2000 to 15.42% in
2009. The corresponding diabetes dialysis rate increased from 1.5% to 2.46% during the same
period (p < 0.001). The prevalence rates of retinopathy and PVD also increased (from 6.17% to
8.91%; pZ 0.002 and from 1.87 to 2.47; p < 0.001, respectively). More than 94% of the patients
treated for diabetic foot in the hospital had an associated foot infection. The prevalence of in-
hospital diabetic foot decreased from 1.68% to 1.02% during the years 2000e2009 (p < 0.001),
while the rates of lower extremity amputation as the treatment outcome did not show
improvement (mean amputation rate: 28.35%).
Conclusion: During the years 2000e2009, patients with diabetes in Taiwan had an increased
risk for kidney, eye, and PVDs. Multidisciplinary teams need to be set up for the treatment
of complications related to diabetic foot, and preventions programs that are specifically de-
signed to target these complications should now be made mandatory.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
End-stage renal disease (ESRD) has had a serious impact on
public health and health-care economies of nations world-
wide for many decades.1 In Taiwan, patients on dialysis
represented <0.2% of the general population but consumed
over 7.0% of the total medical expenditure.2 The Taiwan
Society of Nephrology reported that the incidence and
prevalence rates for patients with ESRD increased 2.6-fold
from 126 to 331 per million population (pmp) and 3.46-
fold from 382 to 1322 pmp, respectively, between the
years 1990 and 2001.3 Increased ESRD was seen in middle-
aged and elderly patients, and in patients who had dia-
betic nephropathy as their primary renal disease during the
years 1990e2001.3
The 2005 annual report of the United States Renal Data
System (USRDS) reported that Taiwan had the world’s
highest incidence and the second highest prevalence of
ESRD during the years 2002e2005.4 The 2011 USRDS annual
report demonstrated that the prevalence and the incidence
of ESRD reached 2444 pmp. In addition, Taiwan had the
world’s highest prevalence and second highest incidence of
ESRD in 2009.1 A prospective cohort study based on 462,293
adults in Taiwan showed that the prevalence of chronic
kidney disease was 11.93%, but only 3.54% of participants in
the cohort were aware of their disorder.5
Diabetes is the leading cause of ESRD in Taiwan. The
Taiwan Society of Nephrology has also demonstrated that
annual increase in the prevalence of diabetes was the main
cause of increased ESRD prevalence and incidence in
Taiwan.3 The increasing prevalence of diabetes in Taiwan
has seen an increase in the number of patients at risk of
diabetic nephropathy and subsequent progression to ESRD.
The prevalence of diabetes in Taiwan has been estimated
at 6.2e8.0% of the population aged over 40 years,6 and
among this group, the percentage of people suffering from
diabetic nephropathy may be as high as 39.0%; in addition,
1% of diabetic patients develop ESRD.7,8 Community-based
screening of chronic kidney disease in patients with type
2 diabetes was conducted in 1999e2001. The prevalence
rates of proteinuria and renal impairment were 29.4% and
15.1%, respectively.9
In Taiwan, approximately half of all nontraumatic lower
extremity amputations are performed on patients withdiabetes.10 A previous study showed that the risk of non-
traumatic lower extremity amputation due to diabetic
complications was 9.22 and 11.67 times higher than that in
the nondiabetic population for men and women, respec-
tively.11 Foot problems were present in 2.9% of the patients
with diabetes, and ulcers represented 86.7% of all the
initiating events.12 Nevertheless, no nationwide epidemio-
logic survey of diabetic foot problems in Taiwan has been
carried out and data on the treatment outcomes for dia-
betic foot ulcers are still not available.
The Taiwanese government implemented its National
Health Insurance (NHI) system in 1995. This provided
coverage for 95% of the population in 2000, which increased
to 98% in 2005 and 99.6% of the total 23 million people in
Taiwan in 2009. Large computerized administrative and
claims data sets derived from this program have been
maintained on an ongoing basis by the Collaboration Center
of Health Information Application. In this study, we inves-
tigated the prevalence of kidney, eye, and foot problems in
patients with diabetes using this national database.
Methods
Data source
Executive Yuan of the Department of Health (DOH) makes
this data available to investigators for research purposes
after individual health information is de-identified. The
DOH Mortality Registry uses the same de-identification rules
to link these data with the NHI claims data. In this study,
inpatient and outpatient claims data sets for 2000e2009
were used. This study was approved by the Institutional
Review Board of National Taiwan University Hospital.
Study population
We used diagnostic code 250 for diabetes mellitus accord-
ing to the International Classification of Diseases, 9th
Revision with Clinical Modification (ICD-9-CM) diagnosis
codes. Before June 2000, an A code (A181) was used for
outpatients only. To protect personal privacy, the National
Health Research Institutes provided only one-third of the
randomly sampled patients who were identified as having
Diabetes-related kidney, eye, and foot diseases 639been hospitalized or having made an ambulatory visit for
diabetes (ICD-9-CM code 250 and A code A181) from 2000 to
2009. Patients were classified as diabetic and included in
the analysis if they had at least one admission code for
diabetes or three or more outpatient codes within 365
calendar days. To avoid the accumulation of misdiagnosed
patients, we used the selection method described every
year.
Demographic factors
Information about demographic factors such as age and
gender was obtained directly from the individual NHI files.
Age was divided into three categories: <40, 40e65, and
>65 years.
Complications
ICD-9, procedure code, and A codes for complications are
provided below:
(1) Kidney disease
(1a) All types of nephropathy: 250.4, 403, 404, 585, 586,
581.8x, 791.0, 593.9, v42.0, v45.1, v56.0, v56.8, 39.27,
39.42, 39.43, 39.49, 39.50, 39.53, 39.93, 39.94, 39.95
(A350).
(1b) Chronic renal failure: 585/renal transplantation
V42.0/dialysis 39.95, v45.1, v56.0, v56.8,
CURE_ITEM_NO1-4: D8 (hemodialysis) D9 (peritoneal
dialysis).
(2) Eye diseases
(2a) All types of eye disease: 362.01, 362.02, 362.53,
362.83, 364.42, 379.23, 369.xx, 14.2xe14.5x, 14.7
(A232).
(2b) Blindness and poor vision: 369.xx/photocoagulation
14.23, 14.24, 14.25, 14.33, 14.34, 14.35, 14.53, 14.54,
14.55/surgery 14.21, 14.22, 14.26, 14.27, 14.29, 14.31,
14.32, 14.39, 14.4, 14.51, 14.52, 14.59, 14.7.
(3) Peripheral vascular disease
(3a) All forms of peripheral vascular disease (PVD) 440.2x,
443.9, 84.1x, 39.25, 39.29, 39.50, 39.59 (A300, A301,
A302).
(3b) Amputation of lower limb 84.1x (nontraumatic,
excluding ICD 800-999)/blood vessel bypass surgery
39.25, 39.29, 39.59/percutaneous transluminal angio-
plasty 39.50.
(4) Foot disease
(4a) All forms of foot disease: foot gangrene 040.0, 440.24,
785.4 with 250.7 or 440.2, 440.21, 440.22, and 440.23/
foot osteomyelitis 730.07, 730.17, 730.27, 730.97,
440.23, 707.14, 707.15, 707.1/cellulitis or abscess of
foot 680.7, 682.7, 681.1, 681.10.
(4b) Foot amputation (ICD-9-CM codes): V49.71-77; V52.1
and (ICD-9 procedure codes): 84.11-17.Statistical analysis
We performed trend analysis to examine linear gradient
relationship with the risk of end points of interest. Pearson
correlation was used to estimate the correlation betweentwo variables. All statistical analyses were performed
using SAS version 9.1 (SAS Institute, Cary, NC, USA). A
p value < 0.05 was considered to be statistically
significant.
Results
Prevalence of nephropathy, chronic renal failure/
dialysis/transplant, and dialysis
As shown in Table 1, the total numbers of patients with
diabetes in Taiwan increased from 70,000 to 1,205,000 over
the period 2000e2009, respectively. For these patients with
diabetes, the prevalence rate of nephropathy were 12.32%
to 15.42%, respectively, and showed a significant increase by
year. The prevalence rate (1.50%, 1.54%, 1.67%, 1.80%,
1.87%, 1.94%, 2.10%, 2.27%, 2.36%, and 2.46%) for dialysis
also increased steadily and significantly throughout the
2000e2009 study period.
Prevalence of diabetic kidney disease in age- and
gender-specific groups
Fig. 1 shows progressively increasing prevalent rates of
nephropathy, chronic renal failure (CRF)/dialysis/trans-
plant, and for patients on dialysis in the middle-aged
(40e65 years) and elderly (>65 years) groups. After
adjusting for each age-specific population, the elderly (>65
years) group showed the greatest increase in the preva-
lence of nephropathy, CRF/dialysis/transplant, and dial-
ysis. The prevalence rates of nephropathy and CRF/
dialysis/transplant were higher among the male patients
than that among the female patients.
Prevalence of diabetic eye disease during the
period 2000e2009
As shown in Table 2, the prevalence rates of retinopathy
were 6.17%, 6.94%, 7.76%, 7.84%, 8.33%, 8.70%, 8.63%,
8.37%, 8.30%, and 8.91% in 2000, 2001, 2002, 2003, 2004,
2005, 2006, 2007, 2008, and 2009, respectively. The prev-
alence rates of poor vision/blindness were 0.50%, 0.53%,
0.52%, 0.53%, 0.50%, 0.48%, 0.52%, 0.54%, 0.55%, and 0.62%
for the 2000e2009 study period.
Prevalence of diabetic eye disease in the age- and
gender-specific groups
Fig. 2 shows that the prevalence rates of retinopathy in the
middle-aged (40e65 years) and elderly (>65 years) groups
are higher than that in the young (<40 years) group. The
prevalence rate of retinopathy in male patients aged >40
years is higher than that in female patients in the same age
group.
Prevalence of PVD (outpatient setting) for
2000e2009
The prevalence rates for diabetic patients with associated
PVD were 1.87%, 1.83%, 1.85%, 1.95%, 2.19%, 2.29%, 2.37%,
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Figure 1 Prevalence of diabetes-related kidney disease by
gender and age in Taiwan for 2000e2009. CRFZ chronic renal
failure. ** means P < 0.05, *** means P < 0.05 compared to
each group.
640 Y.-Y. Huang et al.2.35%, 2.42%, and 2.47% in 2000, 2001, 2002, 2003, 2004,
2005, 2006, 2007, 2008, and 2009, respectively, which
shows a significant increase (p < 0.001).
Prevalence of diabetic foot disease (in-hospital
setting) and its high association with foot infection
The prevalence of diabetic foot disease in 2000 was 1.68%
and this gradually decreased to 1.08% in 2009 (p < 0.001)
(Table 3). Nevertheless, the number of annual in-hospital
cases for diabetic foot treatment did not decrease
because there was a concomitant increase in the preva-
lence of diabetes mellitus. Our findings show that approx-
imately 13,000 patients with diabetes were annually
admitted for foot treatment (Table 3).
It is noteworthy that most cases were associated with
foot infection. However, the infection rate declined from
98.1% in 2000 to 94.0% in 2009 (p < 0.001). Foot infection
appeared to be the major problem for patients with dia-
betes who required admission to manage their foot disease.
T
a
b
le
2
P
re
va
le
n
ce
o
f
th
e
d
ia
b
e
ti
c
e
ye
d
is
e
a
se
in
T
a
iw
a
n
in
20
00
e
20
09
.
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
P
fo
r
tr
e
n
d
R
e
ti
n
o
p
a
th
y
(N
)
43
,6
23
51
,8
58
63
,1
41
68
,0
76
78
,6
75
86
,9
31
91
,0
92
94
,4
37
10
0,
00
2
10
8,
90
6
R
e
ti
n
o
p
a
th
y
(%
)
6.
17
6.
94
7.
76
7.
84
8.
33
8.
70
8.
63
8.
37
8.
30
8.
91
0.
00
2
P
o
o
r
vi
si
o
n
/b
li
n
d
n
e
ss
(N
)
3,
51
0
3,
93
6
4,
20
0
4,
56
6
4,
68
9
4,
84
2
5,
43
6
6,
06
9
6,
66
0
7,
62
3
P
o
o
r
vi
si
o
n
/b
li
n
d
n
e
ss
(%
)
0.
50
0.
53
0.
52
0.
53
0.
50
0.
48
0.
52
0.
54
0.
55
0.
62
0.
00
1
Figure 2 Prevalence of the retinopathy and low vision/
blindness by gender and age in Taiwan for 2000e2009. * means
P < 0.05, ** means P < 0.05 compared to each group.
Diabetes-related kidney, eye, and foot diseases 641Among these foot infections, the prevalence of severe
foot gangrene significantly decreased from 64% in year 2000
to 43% in year 2009. However, there was an increase in the
number of cases of cellulitis or abscess of the foot (from
25.6% in 2000 to 41.9% in 2009; p < 0.001). Osteomyelitis
cases had an annual incidence between 34% and 39% and
showed a moderate upward trend (p Z 0.03).
Age and gender distribution of PVD and foot
infection in 2009
The gender ratio among diabetic patients with associated
PVD was relatively similar compared with the predomi-
nance of males among patients with foot infection (Fig. 3).
The male-to-female gender ratio was 1.29 for foot infection
cases in 2009, and younger males had a much higher prev-
alence than younger females (Fig. 3).
Amputation outcomes for in-hospital foot
treatment
The level of lower extremity amputation is undifferentiated
in the study. Thus, amputations here include minor (below
the ankle) and major (above the ankle) amputations. Table
3 shows that the amputation rate for patients with diabetes
admitted for foot treatment varied from 24.96% to 30.90%
during the years 2000e2009, with the mean being 28.35%.
The amputation outcome did not show improvement from
2000 to 2009. Lower extremity amputation was higher for
males and older people. The prevalence rates were 0.54%,
12.02%, and 30.78% in women aged <40, 40e65, and >65
years, respectively. Among men, the prevalence rates were
Figure 3 Age and gender distribution of patients with dia-
betes associated with peripheral vascular diseases (PVDs) and
foot infections (2009).
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642 Y.-Y. Huang et al.1.55%, 23.49%, and 31.63% for men aged <40, 40e65, and
>65 years, respectively.Discussion
The current study found that the prevalence of nephrop-
athy among patients with diabetes in Taiwan increased
from 13.32% in 2000 to 15.42% in 2009. Notably, this prev-
alence rate is similar to that for renal impairment (15.1%;
estimated glomerular filtration rate < 60 mL/minute) seen
in the Kinmen-based study of Lin et al, but it is lower than
that of proteinuria (29.4%; urine protein-to-creatinine ratio
>0.2 mg/g, approximately 250 mg/day) seen in that study.9
Results of one multicenter, hospital-based, randomly
selected, cross-sectional study also showed the prevalence
rate of CRF stage 3e5 was 13.8% in patients with type 2
diabetes without known diagnosis of proteinuria.12 In this
study, the prevalence rate of microalbuminuria was 26.9%.
Thus, it appears that the prevalence rate of nephropathy
estimated by the definition with ICD-9, op code, and A code
is similar to that of CRF. However, the prevalence of
nephropathy in the current study is markedly lower than
that of microalbuminuria or proteinuria in patients with
diabetes. This indicates that we need to carry out early
screening of proteinuria or urine albumin-to-creatinine
ratios in patients with diabetes.
In the general population, the prevalence of CRF stage
3e5 was reported to be 7e1% by Wen et al.5 In Taiwan,
patients on dialysis represented <0.2% of the general
population. The Taiwan Society of Nephrology reported
that an annually increasing prevalence of diabetes was the
main cause for increases in ESRD prevalence and incidence.
In patients with diabetes, the prevalence of nephropathy
(13.32% in 2000 and 15.42% in 2009) is higher in this study.
The NHI data confirms that diabetes is the major cause of
ESRD and creates a serious economic burden in Taiwan.
High HbA1c levels and hypertension are shown to be
potential predictors of the development of micro-
albuminuria in Taiwanese patients with type 2 diabetes.5
One prospective study confirmed that poor glycemic
control, high blood pressure, and low education are
potential predictors of the development of diabetic
nephropathy in Taiwanese patients with type 2
Diabetes-related kidney, eye, and foot diseases 643diabetes.13,14 Therefore, early intensive glycemic and
blood pressure control can effectively prevent the occur-
rence of diabetic nephropathy.15
The presence of peripheral neuropathy, PVD, and poor
glycemic control in conjunction with minor foot trauma
increases the likelihood that patients with diabetes will
develop foot ulcers.16 Ulcers, in turn, often progress to
infections of the surrounding tissues, osteomyelitis,
gangrene, and amputation. Our survey found that foot
infection is a leading cause of in-hospital foot disease.
Hence, men predominate in terms of figures for infectious
foot disease.17
There was a discrepancy in the trend among Taiwan dia-
betic patients with PVDs or foot diseases from 2000 to 2009.
The prevalence rate of PVD increased while the rates of in-
hospital foot disease declined. Because there is a close
association between in-hospital foot disease and foot infec-
tion, the decrease in the incidence of annual foot disease
might be related to better foot hygiene or foot care during
the study period. The decrease in foot gangrene rates might
indirectly support this hypothesis. Nevertheless, there was
a very high percentage (43%) of gangrene cases among the in-
hospital foot diseases in the year 2009. This indicates that
ignorance of or delays in the management of foot diseases
are still common in Taiwan. This might also suggest that we
have underestimated foot disease rates in our survey
because certain less severe foot caseswere treated at clinics
without being recorded as in-hospital.
For our study period, we found that the mean amputa-
tion rate was 28.35%; this figure was 29.33% in 2009. This
figure for amputation includes all levels of lower extremity
amputation. Nevertheless, the outcome for diabetic foot
treatment seems unsatisfactory, and we found no trend
toward a reduction in amputations in the 10 years covered
by our study. Treatment of diabetic foot diseases depends
on multidisciplinary teams able to care for all the aspects of
wound growth, blood flow, infection, and systemic
diseases.18,19 One recent study in Taiwan suggested both
foot infection control and revascularization are important
to reduce amputation rates in patients with diabetes.20 The
establishment and training of such multidisciplinary teams
are therefore an important issue for diabetic foot care in
Taiwan in coming years.
In conclusion, our reviewofdata for theperiod 2000e2009
found increasing prevalence of diabetes-related kidney and
eye diseases, and PVDs. These data indicate that current
diabetes treatment is not adequate. It is important to
recognize the potential risks of severe morbidity related to
these complications; widespread preventive programs for
patients with diabetes should be set up.21e23 In addition,
multidisciplinary teams are necessary to treat in-hospital
diabetic foot and reduce amputation rates.
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